ପ୍ରୋଜେଷ୍ଟିନ-କେବଳ ବଟିକା

Progestin-only pill
Progestin-only pill
Background
Type	Hormonal
First use	1968
Synonyms	Progestogen-only pill, mini pill
Failure rates (first year)
Perfect use	0.3%
Typical use	9%
Usage
Reversibility	Yes
User reminders	Taken within same 3-hour window each day
Advantages and disadvantages
STI protection	None
Weight	No clear effect
Period disadvantages	Irregular bleeding
Period advantages	Lighter and less painful
Medical notes
	May be used in high blood pressure or migraines. Affected by some anti-seizure medication.

ପ୍ରୋଜେଷ୍ଟିନ-କେବଳ ବଟିକା (ଇଂରାଜୀ ଭାଷାରେ Progestin-only pills/ POP/ ପିଓପି ), ମିନିପିଲ ଭାବରେ ମଧ୍ୟ ଜଣାଶୁଣା, ହେଉଛି ଏକ ପ୍ରକାର ଜନ୍ମ ନିୟନ୍ତ୍ରଣ ବଟିକା ଯେଉଁଥିରେ କେବଳ ପ୍ରୋଜେଷ୍ଟୋଜେନ ( ପ୍ରୋଜେଷ୍ଟିନ୍ ) ଥାଏ ଏବଂ ଇଷ୍ଟ୍ରୋଜେନ୍ ନ ଥାଏ ।^[୩] ସାଧାରଣ ବ୍ୟବହାର ସହିତ ପ୍ରଥମ ବର୍ଷରେ ପ୍ରାୟ ୯% ଗର୍ଭବତୀ ହୋଇଥିବାବେଳେ ସଂପୂର୍ଣ୍ଣ ବ୍ୟବହାର କଲେ ଏହା 0.୩% ଗର୍ଭବତୀ ହୁଅନ୍ତି ।^[୪] ^[୩] ଋତୁଶୂଳ, ଏଣ୍ଡୋମେଟ୍ରିଓସିସ୍, ଏବଂ ସିକ୍ଲ ଜୀବକୋଷ ରୋଗମାନଙ୍କରେ ଏହା ବ୍ୟବ‌ହୃତ ହୋଇପାରେ ।^[୫] ବ୍ୟବହାର ବନ୍ଦ କରିବା ପରେ ଉର୍ବରତା ତୁରନ୍ତ ଫେରିଯାଏ ।^[୩]

ଏହି ଔଷଧ ଜନିତ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟା କମ୍ ହୁଏ, ରକ୍ତ ଜମାଟ ବାନ୍ଧିବା କିମ୍ବା ସ୍ତନ କର୍କଟ ହେବାର ଆଶଙ୍କା ନ ଥାଏ ।^[୩] କିନ୍ତୁ ଅନିୟମିତ ଯୋନୀ ରକ୍ତସ୍ରାବ ହୋଇପାରେ ।^[୩] ଫଳପ୍ରଦ ହେବା ନିମନ୍ତେ ଏହା ପ୍ରତ୍ୟେକ ଦିନ ସମାନ ସମୟରେ ବ୍ୟବହାର କରିବା ଆବଶ୍ୟକ ହୁଏ ।^[୩] ଏହା ଯୌନ କ୍ରିୟା ସଞ୍ଚାରିତ ରୋଗ ସମୂହରୁ (STI) ରକ୍ଷା କରନ୍ତି ନାହିଁ ।^[୫] ସ୍ତନ୍ୟପାନ ସମୟରେ ସେଗୁଡିକ ବ୍ୟବହାର କରାଯାଇପାରେ ।^[୩] ସେମାନେ ମୁଖ୍ୟତ ଡିମ୍ବାଣୁ ମୋଚନ ବନ୍ଦ କରି କାର୍ଯ୍ୟକ୍ଷମ ହୁଅନ୍ତି ।^[୫]

୧୯୬୮ ମସିହାରେ ଫ୍ରାନ୍ସରେ ପ୍ରୋଜେଷ୍ଟିନ-ବଟିକା ଚିକିତ୍ସା ବ୍ୟବହାରରେ ଆସିଥିଲା ।^[୧] ବର୍ତ୍ତମାନ ସେଠାରେ ଅନେକ ପ୍ରୋଜେଷ୍ଟିନ୍-କେବଳ ସୂତ୍ର ଅଛି | ^[୩] ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ୨୦୨୩ରେ କାଉଣ୍ଟର ବିକ୍ରୟ ପାଇଁ ନରେଷ୍ଟ୍ରେଲ୍ ଅନୁମୋଦିତ ହୋଇଥିଲା ।^[୭] ^[୩] ଏହା ଆରମ୍ଭ କରିବା ପୂର୍ବରୁ କୌଣସି ପରୀକ୍ଷା ଆବଶ୍ୟକ ନାହିଁ ।^[୪] ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଏହା ପିଛା ୨୦୨୩ ସୁଦ୍ଧା ମାସକୁ ୨୫ରୁ ୨୦୦ ଡଲାର ମଧ୍ୟରେ ଖର୍ଚ୍ଚ ହୁଏ ।^[୩]

ଆଧାର

↑ ^୧.୦ ^୧.୧ Annetine Gelijns (1991). Innovation in Clinical Practice: The Dynamics of Medical Technology Development. National Academies. pp. 172–. NAP:13513. Archived from the original on 2023-07-15. Retrieved 2023-07-11. Syntex was the first to introduce a 0.5 milligram chlormadinone acetate minipill in 1968 in France, although this pill was withdrawn from the market in 1970 when long-term animal toxicity tests for the FDA revealed the occurrence of breast nodules in beagles. Nevertheless, other manufacturers began to pursue minipill development using their own progestogens, and since 1970 a variety of compounds have been introduced.
↑ ^୨.୦ ^୨.୧ Trussell, James (2011). "Contraceptive efficacy". In Hatcher, Robert A.; Trussell, James; Nelson, Anita L.; Cates, Willard Jr.; Kowal, Deborah; Policar, Michael S. (eds.). Contraceptive technology (20th revised ed.). New York: Ardent Media. pp. 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. Archived 2013-11-12 at the Wayback Machine.
↑ ^୩.୦୦ ^୩.୦୧ ^୩.୦୨ ^୩.୦୩ ^୩.୦୪ ^୩.୦୫ ^୩.୦୬ ^୩.୦୭ ^୩.୦୮ ^୩.୦୯ ^୩.୧୦ ^୩.୧୧ ^୩.୧୨ ^୩.୧୩ ^୩.୧୪ ^୩.୧୫ Cason, Patty; Cwiak, Carrie; Kowal, Deborah; Edelman, Alison (26 September 2023). Contraceptive Technology (in ଇଂରାଜୀ) (22 ed.). Jones & Bartlett Learning. pp. 419–428. ISBN 978-1-284-25503-4. Archived from the original on 10 April 2024. Retrieved 9 April 2024. Archived 10 April 2024 at the Wayback Machine.
↑ ^୪.୦ ^୪.୧ ^୪.୨ "Progestin-Only Pills - US SPR | CDC". www.cdc.gov (in ଆମେରିକୀୟ ଇଂରାଜୀ). 28 March 2023. Archived from the original on 9 April 2024. Retrieved 9 April 2024. Archived 9 April 2024 at the Wayback Machine.
↑ ^୫.୦ ^୫.୧ ^୫.୨ ^୫.୩ ^୫.୪ "What is the progestogen-only pill?". nhs.uk (in ଇଂରାଜୀ). 29 February 2024. Archived from the original on 10 April 2024. Retrieved 9 April 2024. Archived 10 April 2024 at the Wayback Machine.
↑ "Side effects and risks of the progestogen-only pill". nhs.uk (in ଇଂରାଜୀ). 29 February 2024. Archived from the original on 10 April 2024. Retrieved 9 April 2024. Archived 10 April 2024 at the Wayback Machine.
↑ Perrone, Matthew (13 July 2023). "First over-the-counter birth control pill gets FDA approval in U.S." CBC. Archived from the original on 15 July 2023. Retrieved 13 July 2023. Archived 15 July 2023 at the Wayback Machine.

[Gel1991-1] ୧.୦ ^୧.୧ Annetine Gelijns (1991). Innovation in Clinical Practice: The Dynamics of Medical Technology Development. National Academies. pp. 172–. NAP:13513. Archived from the original on 2023-07-15. Retrieved 2023-07-11. Syntex was the first to introduce a 0.5 milligram chlormadinone acetate minipill in 1968 in France, although this pill was withdrawn from the market in 1970 when long-term animal toxicity tests for the FDA revealed the occurrence of breast nodules in beagles. Nevertheless, other manufacturers began to pursue minipill development using their own progestogens, and since 1970 a variety of compounds have been introduced.

[Trus2011-2] ୨.୦ ^୨.୧ Trussell, James (2011). "Contraceptive efficacy". In Hatcher, Robert A.; Trussell, James; Nelson, Anita L.; Cates, Willard Jr.; Kowal, Deborah; Policar, Michael S. (eds.). Contraceptive technology (20th revised ed.). New York: Ardent Media. pp. 779–863. ISBN 978-1-59708-004-0. ISSN 0091-9721. OCLC 781956734. Table 26–1 = Table 3–2 Percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception, and the percentage continuing use at the end of the first year. United States. Archived 2013-11-12 at the Wayback Machine.

[CT2023-3] ୩.୦୦ ^୩.୦୧ ^୩.୦୨ ^୩.୦୩ ^୩.୦୪ ^୩.୦୫ ^୩.୦୬ ^୩.୦୭ ^୩.୦୮ ^୩.୦୯ ^୩.୧୦ ^୩.୧୧ ^୩.୧୨ ^୩.୧୩ ^୩.୧୪ ^୩.୧୫ Cason, Patty; Cwiak, Carrie; Kowal, Deborah; Edelman, Alison (26 September 2023). Contraceptive Technology (in ଇଂରାଜୀ) (22 ed.). Jones & Bartlett Learning. pp. 419–428. ISBN 978-1-284-25503-4. Archived from the original on 10 April 2024. Retrieved 9 April 2024. Archived 10 April 2024 at the Wayback Machine.

[CDC2024-4] ୪.୦ ^୪.୧ ^୪.୨ "Progestin-Only Pills - US SPR | CDC". www.cdc.gov (in ଆମେରିକୀୟ ଇଂରାଜୀ). 28 March 2023. Archived from the original on 9 April 2024. Retrieved 9 April 2024. Archived 9 April 2024 at the Wayback Machine.

[NHS2024-5] ୫.୦ ^୫.୧ ^୫.୨ ^୫.୩ ^୫.୪ "What is the progestogen-only pill?". nhs.uk (in ଇଂରାଜୀ). 29 February 2024. Archived from the original on 10 April 2024. Retrieved 9 April 2024. Archived 10 April 2024 at the Wayback Machine.

[6] "Side effects and risks of the progestogen-only pill". nhs.uk (in ଇଂରାଜୀ). 29 February 2024. Archived from the original on 10 April 2024. Retrieved 9 April 2024. Archived 10 April 2024 at the Wayback Machine.

[7] Perrone, Matthew (13 July 2023). "First over-the-counter birth control pill gets FDA approval in U.S." CBC. Archived from the original on 15 July 2023. Retrieved 13 July 2023. Archived 15 July 2023 at the Wayback Machine.

[୩]

[୪]

[୫]

[୧]

[୨]

[୬]

[୭]